Neurological and Psychiatric Manifestations of Long COVID-19 and Their [18F]FDG PET Findings: A Review
Year: 2023
Type: review
Abstract: For more than two years, lingering sequalae of COVID-19 have been extensively investigated. Approximately 10% of individuals infected by COVID-19 have been found to experience long-term symptoms termed “long COVID-19”. The neurological and psychiatric manifestations of long COVID-19 are of particular concern. While pathogenesis remains unclear, emerging imaging studies have begun to better elucidate certain pathological manifestation. Of specific interest is imaging with [18F]FDG PET which directly reflects cellular glycolysis often linked to metabolic and inflammatory processes. Seeking to understand the molecular basis of neurological features of long COVID-19, this review encompasses the most recent [18F]FDG PET literature in this area.
Source: Diagnostics
Institutions: Interfaith Medical Center, Kingsbrook Jewish Medical Center, Stanford Medicine, Stanford University, Medical University of the Americas, Tbilisi State Medical University, Touro College, Russells Hall Hospital, Dartmouth College, University of South Florida, Harvard University, Hospital of the University of Pennsylvania, Oslo University Hospital, University of Oslo
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,224
OpenAlex ID: W4384202926